Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Heparin-Induced Thrombocytopenia
0
Clinical Trials
6
Meta-Analyses
0
PubMed References
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42020146770
Systematic reviews and meta-analyses on the treatment and management of heparin-induced thrombocytopenia: a review of reviews
Approximately 12 million hospitalized patients each year are exposed to heparin
CRD42020188701
Anticoagulant management of pediatric heparin-induced thrombocytopenia during cardiopulmonary bypass surgery
Heparin-induced thrombocytopenia is a rare thrombotic disorder with high morbidi
CRD42021240788
Characteristics, outcomes and incidence of heparin-induced thrombocytopenia (HIT) in patients with COVID-19
Incidence of heparin-induced thrombocytopenia in patients with COVID-19 who rece
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Heparin-Induced Thrombocytopenia
🏥 Names
Disease Name
Heparin-Induced Thrombocytopenia
Alias Names
Heparin-Induced Thrombocytopenia
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
MeSH Class
Hemic and Lymphatic Diseases
HPO Class
Abnormality of blood and blood-forming tissues
🔗 External References
🔍 Raw view — every non-empty column on this row (25 fields)
name
Heparin-Induced Thrombocytopenia
alias name
Heparin-Induced Thrombocytopenia
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
mesh disease class
Hemic and Lymphatic Diseases
hpo disease class
Abnormality of blood and blood-forming tissues
umls disease type id
T047
mesh disease class id
C15
hpo disease class id
HP:0001871
herb disease id
HBDIS006752
disgenet id
C0272285
hpo id
HP:0011874
📊 Meta-Analyses
6 · systematic reviewCRD42020146770 Systematic reviews and meta-analyses on the treatment and management of heparin-
→ Approximately 12 million hospitalized patients eac
CRD42020188701 Anticoagulant management of pediatric heparin-induced thrombocytopenia during ca
→ Heparin-induced thrombocytopenia is a rare thrombo
CRD42021240788 Characteristics, outcomes and incidence of heparin-induced thrombocytopenia (HIT
→ Incidence of heparin-induced thrombocytopenia in p
CRD42021249652 Cerebral venous thrombosis in patients with heparin-induced thrombocytopenia - a
→ Cerebral venous thrombosis in patients with hepari
CRD42021259546 Incidence of heparin-induced thrombocytopenia in patients with COVID-19: a meta-
→ COVID-19; heparin-induced thrombocytopenia
CRD42023452771 Incidence of Heparin-induced thrombocytopenia in patients with COVID-19: a syste
→ Incidence and significance of heparin-induced thro
How to read these connections
Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.
- Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
- Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
- Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.